[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-378214-110":3,"detail-sidebar-cat-0-es-110":80,"doc-detail-378214-es":123},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},110,"es","survival-of-cancer-patients-in-navarre-and-comparison-with-spain","Supervivencia de los pacientes con cáncer en Navarra y comparación con España","","Análisis de la supervivencia de pacientes adultos diagnosticados de cáncer en Navarra y comparación con las cifras de España. Se emplea el registro poblacional de cáncer de Navarra para dos periodos (1999-2007 y 2008-2016), con actualización del estado vital hasta 2020. Se estiman supervivencia observada, supervivencia neta y supervivencia neta estandarizada a cinco años con intervalos de confianza del 95%, globalmente y para veintinueve grupos oncológicos. En conjunto se analizan 57.564 casos, observándose mejoras y diferencias entre Navarra y España.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/es/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/es/document/investigación-e-informes/","Investigación e Informes",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/es/document/survival-of-cancer-patients-in-navarre-and-comparison-with-spain/378214/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/survival-of-cancer-patients-in-navarre-and-comparison-with-spain/378214.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-09-29","2026-09-24",true,{"@type":52,"interactionType":53,"userInteractionCount":22},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"Qué objetivo persigue el estudio sobre cáncer en Navarra?","Question",{"text":62,"@type":63},"Analiza la supervivencia de pacientes adultos con cáncer en Navarra, describe su tendencia y la compara con la supervivencia en España.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Qué periodos y fuente de datos se utilizan?",{"text":67,"@type":63},"Se recuperan casos del registro poblacional de cáncer de Navarra para 1999-2007 y 2008-2016, con estado vital actualizado hasta 2020.",{"name":69,"@type":60,"acceptedAnswer":70},"Cómo se estiman la supervivencia y los intervalos de confianza?",{"text":71,"@type":63},"Se calculan supervivencia observada, supervivencia neta y supervivencia neta estandarizada a cinco años, con intervalos de confianza del 95%.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},378214,1790671584,{"code":4,"msg":81,"data":82},"success",[83,88,92,96,100,103,107,111,115,119],{"id":84,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},39,"Cómic",60,"comic",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":86,"slug":91},43,"Estilo de Vida","lifestyle",{"id":93,"doc_module":4,"doc_module_name":25,"category_name":94,"show_sort_weight":86,"slug":95},38,"Examen","exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":86,"slug":99},44,"General","general",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":86,"slug":102},41,"research-report",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":105,"show_sort_weight":86,"slug":106},37,"Literatura","literature",{"id":108,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":86,"slug":110},22,"Relatos y Novelas","story-novel",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":113,"show_sort_weight":86,"slug":114},42,"Religión y Espiritualidad","religion-spirituality",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":86,"slug":118},40,"Salud y Atención Médica","healthcare",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":86,"slug":122},24,"Tecnología","technology",{"code":4,"msg":81,"data":124},{"doc_id":78,"user_id":125,"nickname":42,"user_avatar":126,"doc_module":4,"category_id":101,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":22,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":132,"language":133,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":134,"faqs":135,"seo_title":136,"seo_description":12,"update_tm":137,"read_time":108},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","DEL SISTEMA SANITARIO DE NAVARRA  \nAn Sist Sanit Navar 2023; 46(2): e1042 [https://doi.org/10.23938/ASSN.1042](https://doi.org/10.23938/ASSN.1042)  \neISSN: 2340-3527 • ISSN: 1137-6627  \n[https://recyt.fecyt.es/index.php/ASSN/](https://recyt.fecyt.es/index.php/ASSN/)  \nARTÍCULOS ORIGINALES  \nSupervivencia de los pacientes con cáncer en Navarra y comparacióncon España  \nSurvival of cancer patients in Navarre and comparison with Spain  \nMarcela Guevara1,2,3, Miren Baztan1, Rosana Burgui1,2, Alberto Ovies1, Aitziber Menéndez1, Maribel Eciolaza1, Conchi Moreno-Iribas1,2,3, Eva Ardanaz1,2,3  \n\n| RESUMEN | ABSTRACT |\n| --- | --- |\n| Fundamento. Analizar la supervivencia de pacientes adultos | Background. To analyze the survival of adult cancer patients in |\n| diagnosticados de cáncer en Navarra, describir su tendencia y | Navarre, describe its trend, and compare the data for this Span- |\n| compararla con la supervivencia en España. | ish Autonomous Community against that reported for Spain. |\n| Métodos. Los casos de personas adultas diagnosticadas de | Methods. Records of adult cancer patients were retrieved from |\n| cáncer en los periodos 1999-2007 y 2008-2016 fueron seleccio- | the Navarre’s population-based cancer registry for two periods |\n| nados del registro poblacional de cáncer de Navarra; su esta- | (1999-2007 and 2008-2016). The vital status had been updated to |\n| do vital se había actualizado hasta 2020. La supervivencia ob- | 2020. Observed survival, net survival and age-standardized net |\n| servada, la supervivencia neta (SN) y la SN estandarizada por | survival at five years with 95% confidence intervals were esti- |\n| edad (SNe) a cinco años, junto con sus intervalos de confianza | mated overall and for twenty-nine cancer groups |\n| al 95%, fueron estimados globalmente y para veintinueve grupos de cáncer. | Results. We analyzed 57,564 cases. Age-standardized net survival was 59.9%(59.1-60.8) and 63.8%(62.8-64.7) for males and |\n| Resultados. Se analizaron 57.564 casos. La SNe de los hombres | females diagnosed with cancer during the 2008-2016 period, |\n| y mujeres diagnosticados en 2008-2016 fue 59,9%(59,1-60,8) y | respectively. Age-standardized net survival ranged from 13.4% |\n| 63,8%(62,8-64,7), respectivamente. En hombres varió desde | (10.4-17.4) for pancreatic cancer to 94.0%(88.1-100) for thyroid |\n| 13,4%(10,4-17,4) en cáncer de páncreas hasta 94,0%(88,1- 100) en el de tiroides, y en mujeres desde 11,9%(7,2-19,7) en | cancer in male patients, and from 11.9%(7.2-19.7) for liver cancer to 95.6%(92.6-98.6-%) for thyroid cancer in female pa- |\n| el cáncer de hígado hasta 95,6%(92,6-98,6) en el de tiroides. En | tients. Compared with cases diagnosed in the 1999-2007 period, |\n| comparación con los casos diagnosticados en 1999-2007, la SNe | age-standardized net survival increased in 10 cancer groups, re- |\n| aumentó en diez grupos de cáncer, resultando un incremento | sulting in an overall increase of 5.1 (4.1-6.0) percentage points. |\n| global de 5,1 (4,1-6,0) puntos porcentuales. La SNe en Navarra | The age-standardized net survival in Navarre was 2.7 (1.9-3.4) |\n| fue 2,7 (1,9-3,4) puntos porcentuales mayor que la descrita en | percentage points higher than that described for Spain for the |\n| España en 2008-2013. | 2008-2013 period. |\n| Conclusiones. En Navarra la supervivencia de pacientes diagnos- | Conclusions. In Navarre, the survival of cancer patients di- |\n| ticados de cáncer en el periodo 2008-2016 mejoró significativa- | agnosed during the 2008-2016 period improved significantly |\n| mente respecto al periodo 1999-2007. Esta mejora obedece pro- | in comparison to the 1999-2007 period. Different factors may |\n| bablemente a múltiples factores, incluyendo diagnósticos más | explain this improvement, including earlier diagnoses, more |\n| tempranos, opciones terapéuticas más efectivas y mejora del | effective treatment options, and better healthcare processes. |\n| proceso asistencial. La supervivencia globa","cbCaielf4Yp8YDhd","https://ap.wps.com/l/cbCaielf4Yp8YDhd","pdf",956798,14,"Spanish","# Introducción\n# Resumen\n## Fundamento\n## Métodos\n## Resultados\n## Conclusiones\n# Palabras clave","[{\"question\":\"Qué objetivo persigue el estudio sobre cáncer en Navarra?\",\"answer\":\"Analiza la supervivencia de pacientes adultos con cáncer en Navarra, describe su tendencia y la compara con la supervivencia en España.\"},{\"question\":\"Qué periodos y fuente de datos se utilizan?\",\"answer\":\"Se recuperan casos del registro poblacional de cáncer de Navarra para 1999-2007 y 2008-2016, con estado vital actualizado hasta 2020.\"},{\"question\":\"Cómo se estiman la supervivencia y los intervalos de confianza?\",\"answer\":\"Se calculan supervivencia observada, supervivencia neta y supervivencia neta estandarizada a cinco años, con intervalos de confianza del 95%.\"}]","Supervivencia de los pacientes con cáncer en Navarra y comparación con España | PDF",1790228969]